News Archives
The Partnership for Safe Medicines has been publishing information about the counterfeit drug problem around the world for more than a decade. With experts leading the organization and a committed and passionate set of writers and editors, our content is more in-depth than many other sources, which simply copy links to the news from other websites.
This editorial by Dana McDougall was published in The Waterloo Cedar Falls Courier on August 26, 2019. Mr. McDougall, Pharm.D., BCPS, is a pharmacist with the Covenant Cancer Treatment Center in Waterloo, Iowa.
WASHINGTON (August 26, 2019) – Shabbir Imber Safdar, Executive Director of The Partnership for Safe Medicines, released the following statement in response to Florida’s submission of a drug importation concept to the U.S. Department of Health and Human Services (HHS): “Florida’s Canadian Prescription Drug Importation Concept Paper [PDF] recently submitted to HHS demonstrates that Florida…
The Drug Enforcement Administration (DEA) is warning the public after the seizure of counterfeit pills designed to look like Adderall, a medication used to treat Attention-deficit/Hyperactivity Disorder. The pills in question were tested and were found to be composed of illicit methamphetamine.
In a report published by the House of Commons, experts in the field of prescription medication described a dire situation for medicine safety in the United Kingdom (UK) if a “no-deal” departure from the European Union (EU) happens. The report noted, “Witnesses told us that, without provisions with the EU to continue to exchange data, the UK would be shut out of critical EU data exchanges on pharmacovigilance, falsified medicines and clinical trials.”
This editorial by Fergus Hodgson was published in the Epoch Times on August 14, 2019. Mr. Hodgson is an independent economic consultant, and Executive Editor of the Antigua Report.
The Arizona Republic has reported that Executive Director Shabbir Safdar, along with Maricopa County Sheriff Paul Penzone, Pinal County Sheriff Mark Lamb, U.S. Drug Enforcement Administration special agent in charge Doug Coleman, and Phoenix-area pharmacist Randle House and met with U.S. Senator Martha McSally in Arizona on August 8th to seek her assistance and support for efforts to protect the U.S. prescription drug supply from counterfeit medication
John Adams of the Best Medicines Coalition, a Canadian group that represents 28 different patient organizations, has described the Trump administration’s plan to import medication from Canada as a “clear and present danger” to the Canadian prescription drug system, according to AP.
This editorial by Wayne Winegarden, Ph.D. appeared in Forbes on August 7, 2019. Dr. Winegarden is the Managing Editor for EconoSTATS and a senior Fellow in Business and Economics at the Pacific Research Institute.
U.S. Attorney Robert Brewer has issued a public safety warning concerning deadly counterfeit oxycodone pills in San Diego County. NBC San Diego reports, “The U.S. Attorney’s Office said border seizures, prosecutions and overdoses in San Diego County are on pace to reach all-time highs by the end of 2019. The Medical Examiner’s Office reports 50 confirmed fentanyl-related fatal overdoses so far this year, and says 28 more suspected cases are waiting to be confirmed.”
Canadian Prime Minister Justin Trudeau was interviewed today in Iqaluit, and according to CBC Canada, he reassured Canadians that Health Canada is already safeguarding the Canadian prescription drug supply regardless of international pressure.